Data sources

The public sources behind every Atlas answer

Atlas reads the registries and indexes researchers already trust: PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov, NIH RePORTER, CORDIS and the European Patent Office. Every paper, trial, grant and patent it shows keeps a link to its original record.

Where does Atlas get its data?

From public scientific and clinical sources, queried for each project: literature indexes for papers, ClinicalTrials.gov for trials, NIH and EU registries for grants, and the European Patent Office for patents. Atlas does not answer from the open web. The copilot, the knowledge graph and the landscapes work only on what a project has retrieved from these sources, so every statement can be traced back to a record you can open.

With Atlas

  • Keeps the identifier of every record: PMID or DOI, NCT number, grant or project ID, patent number
  • Checks for new papers on every active project each night
  • Watches funding registries every week
  • Shows what it retrieved, what it kept and what stays a candidate

Scientific literature

Papers are searched across several indexes, deduplicated, then kept with their identifiers so each one opens on its original record.

SourceWhat Atlas takes from itUsed for
PubMedUS National Library of Medicine (NCBI E-utilities)Citations and abstracts of biomedical papersBuilding and updating the paper corpus of each project
Europe PMCEMBL-EBIPapers and the grant references attached to themLiterature search and funding acknowledged in papers
OpenAlexOurResearchMetadata of scholarly works across disciplinesWider literature coverage and work metadata
PubMed Central Open AccessUS National Library of MedicineFull text of open-access articlesReading beyond the abstract when the full text is open
UnpaywallOurResearchLocations of legal open-access copies, by DOIFinding the open full text of a paper
CrossrefCrossrefDOI metadata and the funders declared by publishersPaper metadata and who funded the work

Clinical trials

Trials come from the registry with the fields a landscape needs, and keep the registry's own wording.

SourceWhat Atlas takes from itUsed for
ClinicalTrials.govUS National Library of Medicine (API v2)Phase, overall status, lead sponsor and collaborators, start and completion dates, enrollment, interventions, conditions and the reason a trial stoppedTrial landscapes, sponsor views and trial answers in the copilot

Research funding

Public grant registries give amounts, dates and institutions; papers show who paid for the work you are reading.

SourceWhat Atlas takes from itUsed for
NIH RePORTERUS National Institutes of HealthNIH-funded projects, with institution, period and amountFunding intelligence on US public research
CORDISEuropean CommissionEU-funded projects (Horizon Europe, ERC and earlier programmes), with coordinator, budget and datesFunding intelligence on EU research
Europe PMC and CrossrefEMBL-EBI · CrossrefGrants and funders acknowledged in papers, including companiesLinking funders to the papers of a project

Patents

Patent publications are retrieved per project and grouped by family, then scored for relevance to the target.

SourceWhat Atlas takes from itUsed for
EPO Open Patent ServicesEuropean Patent OfficePatent publications, bibliographic data and family membersPatent intelligence on a target or a molecule
SureChEMBLEMBL-EBIChemical structures and biomedical entities annotated in patentsEnriching patents with the compounds, genes and diseases they mention

From a source record to an answer

  1. Retrieval. A project starts from a disease, a target and a few keywords. Atlas queries the sources above and scores each paper and trial against the project.
  2. Selection. The most relevant records enter the corpus; the others stay as candidates you can promote. Nothing is added from outside the sources.
  3. Analysis. Atlas extracts drugs, diseases, genes and endpoints from the papers and links them in a knowledge graph where each relationship keeps the passages it came from.
  4. Answers. The research copilot answers from the corpus, cites the paper or trial behind each statement and says what the sources do not cover.
  5. Updates. New papers are checked for every active project each night, and funding registries each week, so a landscape does not freeze on the day it was built.

To see these sources on a real project, read the KRAS G12C clinical trials Atlas found in non-small cell lung cancer, or the use cases built on the same project.

See them on your own target

We set up a project on your disease and target with you, and you check every source behind it.

Request a demo

11 sources as connected in Atlas on 30 Oct 2026. Europe PMC and Crossref are shown twice, for the papers and for the grants, and counted once. Atlas uses the public APIs and bulk data each provider publishes, under that provider’s terms; source names belong to their owners.